Insider Selling: Exponent (NASDAQ:EXPO) VP Sells $110,643.20 in Stock

Exponent, Inc. (NASDAQ:EXPO) VP Richard Reiss sold 1,280 shares of the business’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $86.44, for a total value of $110,643.20. Following the completion of the sale, the vice president directly owned 1,008 shares in the company, valued at approximately $87,131.52. The trade was a 55.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Exponent Stock Down 2.1%

EXPO opened at $84.02 on Friday. The company has a 50 day moving average of $71.74 and a two-hundred day moving average of $66.95. The company has a market cap of $4.00 billion, a P/E ratio of 36.22 and a beta of 0.66. Exponent, Inc. has a 52-week low of $51.91 and a 52-week high of $90.51.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, October 29th. The business services provider reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.04. The business had revenue of $173.73 million during the quarter, compared to the consensus estimate of $149.64 million. Exponent had a net margin of 17.40% and a return on equity of 34.61%. Exponent’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.55 EPS. Research analysts anticipate that Exponent, Inc. will post 2.36 earnings per share for the current year.

Exponent Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Shareholders of record on Friday, December 4th will be paid a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, December 4th. This represents a $1.24 annualized dividend and a dividend yield of 1.5%. Exponent’s dividend payout ratio (DPR) is 53.45%.

Institutional Investors Weigh In On Exponent

A number of institutional investors have recently added to or reduced their stakes in EXPO. Gibbs Wealth Management raised its holdings in shares of Exponent by 3.1% during the 3rd quarter. Gibbs Wealth Management now owns 4,759 shares of the business services provider’s stock worth $311,000 after acquiring an additional 142 shares during the period. Covestor Ltd increased its position in Exponent by 10.3% in the third quarter. Covestor Ltd now owns 2,050 shares of the business services provider’s stock worth $134,000 after buying an additional 192 shares during the period. Bessemer Group Inc. boosted its position in shares of Exponent by 37.1% in the 1st quarter. Bessemer Group Inc. now owns 717 shares of the business services provider’s stock valued at $47,000 after purchasing an additional 194 shares during the period. State of Michigan Retirement System lifted its holdings in Exponent by 1.7% in the 1st quarter. State of Michigan Retirement System now owns 12,000 shares of the business services provider’s stock worth $783,000 after purchasing an additional 200 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Exponent by 9.4% in the second quarter. GAMMA Investing LLC now owns 2,509 shares of the business services provider’s stock valued at $147,000 after acquiring an additional 216 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.

Wall Street Analyst Weigh In

EXPO has been the topic of a number of recent research reports. JPMorgan Chase & Co. boosted their price target on shares of Exponent from $90.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, October 30th. Zacks Research raised Exponent from a “hold” rating to a “strong-buy” rating in a research note on Monday, November 2nd. Weiss Ratings raised Exponent from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. Finally, UBS Group lifted their price objective on shares of Exponent from $72.00 to $82.00 and gave the stock a “neutral” rating in a research note on Friday, October 30th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $91.00.

Exponent Company Profile

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.